
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $12.8M | $14.4M | $19M | $19.5M | $17.7M | |
Selling, General & Admin | $6.8M | $8.4M | $11.5M | $10M | $8.8M | |
Other Inc / (Exp) | $2.4M | $6.8M | $1.4M | -$1.5M | $4.3M | |
Operating Expenses | $19.7M | $23M | $30.6M | $29.6M | $26.6M | |
Operating Income | -$19.7M | -$23M | -$30.6M | -$29.6M | -$26.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$17.4M | -$15.9M | -$29M | -$29.8M | -$21.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$17.4M | -$15.9M | -$29M | -$29.8M | -$21.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$17.4M | -$15.9M | -$29M | -$29.8M | -$21.8M | |
Basic EPS (Cont. Ops) | -$26.40 | -$8.85 | -$15.30 | -$15.07 | -$6.32 | |
Diluted EPS (Cont. Ops) | -$26.40 | -$8.85 | -$15.30 | -$15.07 | -$6.32 | |
Weighted Average Basic Share | $656.4K | $1.8M | $1.9M | $2M | $3.4M | |
Weighted Average Diluted Share | $656.4K | $1.8M | $1.9M | $2M | $3.4M | |
EBITDA | -$19.5M | -$22.8M | -$30.5M | -$29.5M | -$26.5M | |
EBIT | -$19.7M | -$23M | -$30.6M | -$29.6M | -$26.6M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$19.7M | -$23M | -$30.6M | -$29.6M | -$26.6M | |
Operating Income (Adjusted) | -$19.7M | -$23M | -$30.6M | -$29.6M | -$26.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $4.1M | $4.6M | $5.7M | $4.3M | $3.4M | |
Selling, General & Admin | $1.9M | $2.4M | $2.6M | $2.4M | $2.5M | |
Other Inc / (Exp) | $1.6M | $165K | $47K | $1.5M | -$523K | |
Operating Expenses | $6.1M | $7.1M | $8.4M | $6.7M | $5.9M | |
Operating Income | -$6.1M | -$7.1M | -$8.4M | -$6.7M | -$5.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$4.4M | -$6.9M | -$7.9M | -$5M | -$6.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$4.4M | -$6.9M | -$7.9M | -$5M | -$6.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$4.4M | -$6.9M | -$7.9M | -$5M | -$6.4M | |
Basic EPS (Cont. Ops) | -$3.00 | -$3.60 | -$4.13 | -$2.02 | -$0.69 | |
Diluted EPS (Cont. Ops) | -$3.00 | -$3.60 | -$4.13 | -$2.02 | -$0.69 | |
Weighted Average Basic Share | $1.5M | $1.9M | $1.9M | $2.5M | $9.3M | |
Weighted Average Diluted Share | $1.5M | $1.9M | $1.9M | $2.5M | $9.3M | |
EBITDA | -$6M | -$7M | -$8.3M | -$6.6M | -$5.9M | |
EBIT | -$6.1M | -$7.1M | -$8.4M | -$6.7M | -$5.9M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$6.1M | -$7.1M | -$8.4M | -$6.7M | -$5.9M | |
Operating Income (Adjusted) | -$6.1M | -$7.1M | -$8.4M | -$6.7M | -$5.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $13.7M | $14.9M | $20M | $18.1M | $16.9M | |
Selling, General & Admin | $6.9M | $8.9M | $11.8M | $9.8M | $8.9M | |
Other Inc / (Exp) | $110K | $5.3M | $1.3M | -$87K | $2.3M | |
Operating Expenses | $20.8M | $24M | $31.9M | $28M | $25.9M | |
Operating Income | -$20.8M | -$24M | -$31.9M | -$28M | -$25.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$20.6M | -$18.3M | -$30.1M | -$26.8M | -$23.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$20.6M | -$18.3M | -$30.1M | -$26.8M | -$23.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$20.6M | -$18.3M | -$30.1M | -$26.8M | -$23.2M | |
Basic EPS (Cont. Ops) | -$26.40 | -$9.45 | -$15.83 | -$12.99 | -$4.73 | |
Diluted EPS (Cont. Ops) | -$26.40 | -$9.45 | -$15.83 | -$12.99 | -$4.73 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$20.6M | -$23.8M | -$31.8M | -$27.8M | -$25.8M | |
EBIT | -$20.8M | -$24M | -$31.9M | -$28M | -$25.9M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$20.8M | -$24M | -$31.9M | -$28M | -$25.9M | |
Operating Income (Adjusted) | -$20.8M | -$24M | -$31.9M | -$28M | -$25.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $4.1M | $4.6M | $5.7M | $4.3M | $3.4M | |
Selling, General & Admin | $1.9M | $2.4M | $2.6M | $2.4M | $2.5M | |
Other Inc / (Exp) | $1.6M | $165K | $47K | $1.5M | -$523K | |
Operating Expenses | $6.1M | $7.1M | $8.4M | $6.7M | $5.9M | |
Operating Income | -$6.1M | -$7.1M | -$8.4M | -$6.7M | -$5.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$4.4M | -$6.9M | -$7.9M | -$5M | -$6.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$4.4M | -$6.9M | -$7.9M | -$5M | -$6.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$4.4M | -$6.9M | -$7.9M | -$5M | -$6.4M | |
Basic EPS (Cont. Ops) | -$3.00 | -$3.60 | -$4.13 | -$2.02 | -$0.69 | |
Diluted EPS (Cont. Ops) | -$3.00 | -$3.60 | -$4.13 | -$2.02 | -$0.69 | |
Weighted Average Basic Share | $1.5M | $1.9M | $1.9M | $2.5M | $9.3M | |
Weighted Average Diluted Share | $1.5M | $1.9M | $1.9M | $2.5M | $9.3M | |
EBITDA | -$6M | -$7M | -$8.3M | -$6.6M | -$5.9M | |
EBIT | -$6.1M | -$7.1M | -$8.4M | -$6.7M | -$5.9M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$6.1M | -$7.1M | -$8.4M | -$6.7M | -$5.9M | |
Operating Income (Adjusted) | -$6.1M | -$7.1M | -$8.4M | -$6.7M | -$5.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $15.2M | $70.9M | $43.1M | $23.6M | $4.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $2M | $1.5M | $2.4M | $2.6M | $896K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $17.2M | $72.5M | $45.6M | $26.3M | $5.2M | |
Property Plant And Equipment | $685K | $445K | $678K | $796K | $583K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | $11.1M | $11.1M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $29M | $84.1M | $57.4M | $38.2M | $16.9M | |
Accounts Payable | $1.1M | $1.4M | $2.1M | $2.5M | $2M | |
Accrued Expenses | $1.7M | $2.2M | $2.6M | $4.2M | $3.2M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $118K | $96K | $116K | $100K | $120K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $2.9M | $3.6M | $4.8M | $6.8M | $5.4M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $11.3M | $5.1M | $5.2M | $12.1M | $10.9M | |
Common Stock | $69K | $29K | $29K | $33K | $3K | |
Other Common Equity Adj | $65K | $41K | $12K | -$9K | -$41K | |
Common Equity | $17.8M | $79M | $52.2M | $26.1M | $6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $17.8M | $79M | $52.2M | $26.1M | $6M | |
Total Liabilities and Equity | $29M | $84.1M | $57.4M | $38.2M | $16.9M | |
Cash and Short Terms | $15.2M | $70.9M | $43.1M | $23.6M | $4.3M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $86.3M | $66.1M | $37.3M | $16.8M | $7.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | $1.1M | -- | -- | $1.6M | |
Other Current Assets | $1.7M | -- | $2M | $2.1M | -- | |
Total Current Assets | $88M | $67.3M | $39.3M | $19M | $9.3M | |
Property Plant And Equipment | $617K | $393K | $625K | $740K | $525K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $99.8M | $78.8M | $51.1M | $30.8M | $21M | |
Accounts Payable | $1.9M | $2.2M | $1.9M | $2.1M | $2.7M | |
Accrued Expenses | $2.5M | $2.5M | $3.1M | $3.2M | $4.1M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $122K | $77K | -- | $109K | $124K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $4.6M | $4.8M | $5M | $5.4M | $6.9M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $11.3M | $6.1M | $5.4M | $9.3M | $21M | |
Common Stock | $28K | $29K | $30K | $2K | $14K | |
Other Common Equity Adj | $61K | $53K | $8K | -$18K | -$38K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $88.5M | $72.7M | $45.7M | $21.6M | $42K | |
Total Liabilities and Equity | $99.8M | $78.8M | $51.1M | $30.8M | $21M | |
Cash and Short Terms | $86.3M | $66.1M | $37.3M | $16.8M | $7.7M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$17.4M | -$15.9M | -$29M | -$29.8M | -$21.8M | |
Depreciation & Amoritzation | $200K | $164K | $130K | $127K | $126K | |
Stock-Based Compensation | $1.7M | $2.4M | $2.3M | $2M | $1.7M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$17.8M | -$19M | -$27.6M | -$23.6M | -$23.9M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$374K | -$19K | -$67K | -$124K | -$13K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$17K | -$23K | -$23K | -$25K | -$26K | |
Cash From Financing | $22.5M | $74.7M | -$23K | $4.1M | $4.6M | |
Beginning Cash (CF) | $10.7M | $15.2M | $70.9M | $43.1M | $23.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $4.4M | $55.8M | -$27.7M | -$19.6M | -$19.2M | |
Ending Cash (CF) | $15.2M | $70.9M | $43.1M | $23.6M | $4.3M | |
Levered Free Cash Flow | -$18.1M | -$19M | -$27.7M | -$23.7M | -$23.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$4.4M | -$6.9M | -$7.9M | -$5M | -$6.4M | |
Depreciation & Amoritzation | $44K | $32K | $30K | $32K | $31K | |
Stock-Based Compensation | $405K | $527K | $499K | $493K | $485K | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$3.6M | -$4.8M | -$6M | -$6.7M | -$4.6M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$6K | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $74.7M | -- | $141K | -- | $8M | |
Beginning Cash (CF) | $15.2M | $70.9M | $43.1M | $23.6M | $4.3M | |
Foreign Exchange Rate Adjustment | -$4K | $12K | -$4K | -$9K | $3K | |
Additions / Reductions | $71.1M | -$4.8M | -$5.9M | -$6.7M | $3.4M | |
Ending Cash (CF) | $86.3M | $66.1M | $37.3M | $16.8M | $7.7M | |
Levered Free Cash Flow | -$3.6M | -$4.8M | -$6M | -$6.7M | -$4.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$20.6M | -$18.3M | -$30.1M | -$26.8M | -$23.2M | |
Depreciation & Amoritzation | $198K | $152K | $128K | $129K | $125K | |
Stock-Based Compensation | $1.7M | $2.5M | $2.2M | $2M | $1.7M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$17.1M | -$20.1M | -$28.9M | -$24.3M | -$21.7M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$372K | -$25K | -- | -$124K | -$13K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $92M | -$24K | $118K | $4M | $12.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $74.6M | -$20.2M | -$28.8M | -$20.4M | -$9.1M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$17.4M | -$20.1M | -$28.9M | -$24.4M | -$21.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$4.4M | -$6.9M | -$7.9M | -$5M | -$6.4M | |
Depreciation & Amoritzation | $44K | $32K | $30K | $32K | $31K | |
Stock-Based Compensation | $405K | $527K | $499K | $493K | $485K | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$3.6M | -$4.8M | -$6M | -$6.7M | -$4.6M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$6K | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $74.7M | -- | $141K | -- | $8M | |
Beginning Cash (CF) | $15.2M | $70.9M | $43.1M | $23.6M | $4.3M | |
Foreign Exchange Rate Adjustment | -$4K | $12K | -$4K | -$9K | $3K | |
Additions / Reductions | $71.1M | -$4.8M | -$5.9M | -$6.7M | $3.4M | |
Ending Cash (CF) | $86.3M | $66.1M | $37.3M | $16.8M | $7.7M | |
Levered Free Cash Flow | -$3.6M | -$4.8M | -$6M | -$6.7M | -$4.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.